Atrial Fibrillation

Latest News

Ablation Superior to Drug Therapy for Women and Men With A-Fib

For patients with atrial fibrillation, those undergoing ablation have a significantly reduced risk for recurrent AF compared with those receiving drug therapy.

Ring-Like LV Scar Associated With Malignant Arrhythmic Events in Idiopathic Nonsustained Ventricular Arrhythmias

Ring-like nonischemic left ventricular scarring in patients with idiopathic nonsustained ventricular arrhythmias may be associated with malignant arrhythmic events.

Study Reveals Previously Unknown Drug-Associated Arrhythmias

To identify medications with potential proarrhythmic association.

Moderate Alcohol Consumption Does Not Increase Stroke Risk in A-Fib

For patients with atrial fibrillation, low-to-moderate alcohol intake is not associated with an increased risk for stroke or other cardiovascular events.

Underrecognition of AF Symptom Burden Found to Be Associated With Catheter Ablation Underuse

Atrial fibrillation symptom burden was found to be frequently underrecognized.

At-Home Continuous Ambulatory ECG Monitoring Found to Provide Quality Data

A home-based continuous ambulatory ECG monitoring device delivered with at-home instructions was found to be as effective for collecting quality data as in-clinic delivery and monitoring.

Low Iron Storage and Arrhythmogenic Susceptibility in Healthy Women of Childbearing Age

Low iron storage may increase arrhythmogenic susceptibility in healthy women of childbearing age.

Consuming Alcohol May Increase Risk for Atrial Fibrillation

Hazard ratio 1.16 for one drink per day; similar associations seen across types of alcohol.

Lower Risk for CKD Stage Progression Found With Apixaban

Kidney injury may be less among patients with chronic kidney disease and atrial fibrillation taking apixaban versus warfarin for anticoagulation, new research suggests.

Low- vs Standard-Intensity Warfarin Therapy and Thromboembolic Risk in Older Patients With NVAF

Low-intensity warfarin therapy was found to be as effective as standard-intensity I warfarin in lowering the risk for thromboembolism in older patients with nonvalvular atrial fibrillation.